SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001562762-15-000290
Filing Date
2015-11-06
Accepted
2015-11-05 17:46:03
Documents
14
Period of Report
2015-09-30
Filing Date Changed
2015-11-05

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20150930x10q.htm 10-Q 974004
2 EX-10.1 cort-20150930ex10176a7c0.htm EX-10.1 67057
3 EX-10.2 cort-20150930ex102f72397.htm EX-10.2 27570
4 EX-10.3 cort-20150930ex103c9d4e9.htm EX-10.3 55532
5 EX-31.1 cort-20150930xex311.htm EX-31.1 17919
6 EX-31.2 cort-20150930xex312.htm EX-31.2 18333
7 EX-32.1 cort-20150930xex321.htm EX-32.1 9438
8 EX-32.2 cort-20150930xex322.htm EX-32.2 9729
  Complete submission text file 0001562762-15-000290.txt   2866632

Data Files

Seq Description Document Type Size
9 EX-101.INS cort-20150930.xml EX-101.INS 405167
10 EX-101.SCH cort-20150930.xsd EX-101.SCH 19688
11 EX-101.CAL cort-20150930_cal.xml EX-101.CAL 35713
12 EX-101.DEF cort-20150930_def.xml EX-101.DEF 38443
13 EX-101.LAB cort-20150930_lab.xml EX-101.LAB 152640
14 EX-101.PRE cort-20150930_pre.xml EX-101.PRE 121676
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 151201880
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1